1. Home
  2. NIC vs RCUS Comparison

NIC vs RCUS Comparison

Compare NIC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIC
  • RCUS
  • Stock Information
  • Founded
  • NIC 2000
  • RCUS 2015
  • Country
  • NIC United States
  • RCUS United States
  • Employees
  • NIC N/A
  • RCUS N/A
  • Industry
  • NIC Major Banks
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NIC Finance
  • RCUS Health Care
  • Exchange
  • NIC Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • NIC 1.7B
  • RCUS 1.4B
  • IPO Year
  • NIC N/A
  • RCUS 2018
  • Fundamental
  • Price
  • NIC $102.93
  • RCUS $15.14
  • Analyst Decision
  • NIC Hold
  • RCUS Buy
  • Analyst Count
  • NIC 5
  • RCUS 12
  • Target Price
  • NIC $106.40
  • RCUS $34.50
  • AVG Volume (30 Days)
  • NIC 42.7K
  • RCUS 671.3K
  • Earning Date
  • NIC 01-14-2025
  • RCUS 02-19-2025
  • Dividend Yield
  • NIC 1.05%
  • RCUS N/A
  • EPS Growth
  • NIC 102.58
  • RCUS N/A
  • EPS
  • NIC 7.86
  • RCUS N/A
  • Revenue
  • NIC $342,790,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • NIC N/A
  • RCUS $127.65
  • Revenue Next Year
  • NIC $5.27
  • RCUS N/A
  • P/E Ratio
  • NIC $13.09
  • RCUS N/A
  • Revenue Growth
  • NIC 28.93
  • RCUS 119.17
  • 52 Week Low
  • NIC $73.00
  • RCUS $13.52
  • 52 Week High
  • NIC $116.17
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • NIC 35.41
  • RCUS 42.47
  • Support Level
  • NIC $103.28
  • RCUS $14.62
  • Resistance Level
  • NIC $106.97
  • RCUS $16.08
  • Average True Range (ATR)
  • NIC 2.80
  • RCUS 0.78
  • MACD
  • NIC -0.82
  • RCUS -0.15
  • Stochastic Oscillator
  • NIC 3.80
  • RCUS 16.25

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: